XML 29 R18.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONDENSED FINANCIAL INFORMATION OF THE PARENT COMPANY
6 Months Ended
Jan. 31, 2025
Condensed Financial Information Disclosure [Abstract]  
CONDENSED FINANCIAL INFORMATION OF THE PARENT COMPANY

NOTE 10 — CONDENSED FINANCIAL INFORMATION OF THE PARENT COMPANY

 

The Company performed a test on the restricted net assets of its consolidated subsidiaries in accordance with Rule 4-08(e)(3) of Regulation S-X promulgated by the SEC, “General Notes to Financial Statements” and concluded that it was applicable and the Company is required to disclose the required financial statement information for the parent company.

 

The subsidiaries did not pay any dividends to the parent during the periods presented. For the purpose of presenting parent only financial information, the Company records its investment in its subsidiaries under the equity method of accounting. Such investments are presented on the separate parent only balance sheets as “investment in subsidiaries” and the income (loss) of the subsidiaries is presented as “share of income (loss) of subsidiaries.” Certain information and footnote disclosures generally included in financial statements prepared in accordance with U.S. GAAP have been condensed or are not required.

 

PARENT COMPANY BALANCE SHEET

 

          
   January 31,   July 31, 
   2025   2024 
         
ASSETS          
Cash  $11,876   $14,621 
Prepaid expense   5,445    1,820 
Investment in subsidiaries   687,174    781,661 
Total Assets  $704,495   $798,102 
           
LIABILITIES          
Accounts payable and other accrued liabilities   166,800    54,000 
Payable to subsidiaries   512,416    312,416 
Due to related parties   2,271    2,271 
Total Liabilities  $169,071   $56,271 
           
Stockholders’ Equity          
Series A Preferred stock, $0.0001 par value; 80,000 shares authorized; no shares issued and outstanding as of January 31, 2025 and July 31, 2024        
Series B Preferred stock, $0.0001 par value; 80,000 shares authorized; 80,000 shares issued and outstanding as of January 31, 2025 and July 31, 2024   8    8 
Undesignated preferred stock, $0.0001 par value; 19,920,000 shares authorized; no shares issued and outstanding        
Common stock, $0.0001 par value, 100,000,000 shares authorized; 14,781,803 shares issued and outstanding as of January 31, 2025 and July 31, 2024   1,478    1,478 
Additional paid-in capital   962,416    962,416 
Accumulated deficit   (428,478)   (222,071)
Total Stockholders’ Equity   535,424    741,831 
           
Total Liabilities and Stockholders’ Equity  $704,495   $798,102 

 

 

          
   For the six months ended January 31, 
   2025   2024 
         
EXPENSE:          
General and administrative  $(265,185)  $(197,930)
           
OTHER INCOME          
Gain from investment in subsidiaries   31,387    263,279 
Other income net   27,391     
Total other income   58,778    263,279 
           
Net (loss)  $(206,407))  $65,349 

 

PARENT COMPANY STATEMENT OF CASH FLOWS

 

          
   For the six months ended January 31, 
   2025   2024 
         
Cash flows from operating activities:          
Net (loss)  $(206,407)  $65,349 
Adjustments to reconcile net income to net cash provided by operating activities:          
Share of (gain) from investment in subsidiaries   (31,387)   (263,279)
Change in operating assets and liabilities:          
Prepaid expense and other assets   (3,625)   1500 
Accounts payable and other accrued liabilities   112,799    (7,578)
Net cash (used in) operating activities   (128,620)   (204,008)
           
Cash flows from financing activities:          
Proceeds received from private offerings        433,213 
Repayment of operating funds to related party        (178,097)
Operating proceeds from subsidiaries   200,000     
Deferred offering costs incurred   (74,125)    
Net cash provided by financing activities   125,875    255,116 
           
Net (decrease) increase in cash and cash equivalents   (2,745)   51,108 
Cash and cash equivalents at beginning   14,621    66,553 
Cash and cash equivalents at ending  $11,876   $117,661